Skip to main content
Premium Trial:

Request an Annual Quote

Novartis to Help Fund Development of Gen-Probe MDx Platform

NEW YORK (GenomeWeb News) – As part of an expanded agreement between the firms, drug maker Novartis has agreed to help fund development of Gen-Probe's new automated molecular testing platform, Panther, for the blood screening market.

The partners have collaborated since 1998 on nucleic acid tests and instruments for the blood screening market. Under the expanded pact announced today, the firms intend to continue collaborating until the year 2025, and they expect to collaborate on the development of pharmacogenomic tests.

In addition, terms of their previous agreement have been amended. Gen-Probe will continue to be primarily responsible for R&D and manufacturing and Novartis will continue to be responsible for sales and marketing. However, the firms will collaborate more closely on sales, marketing, and distribution strategies. While the partners will share R&D costs, they also will share manufacturing costs.

Gen-Probe also will receive a percentage of end-user revenues that escalate gradually from 2009 until 2015 and will remain constant thereafter.

Another addition to their collaboration is an agreement to evaluate Gen-Probe's technologies in developing companion diagnostics for current or future Novartis therapeutics. Further details regarding specific drugs or disease focus were not provided.

Finally, Gen-Probe said that it expects to report 2009 revenues in the range of $460 million to $490 million, while its earnings per share will be in the range of $1.80 to $2.05. The firm is scheduled to release its 2008 financial results on Feb. 17.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.